SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.50    5.50 (1.57%)
Bid:
354.00
Ask:
358.00
Spread: 4.00 (1.13%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

30 May 2024 14:55

RNS Number : 4552Q
Caledonia Investments PLC
30 May 2024
 

Caledonia Investments plc

Notification of transactions of persons discharging managerial responsibilities ("PDMR") or persons closely associated with them ("PCA")

 

Pursuant to the requirements of the Market Abuse Regulation, Caledonia Investments plc ("Caledonia" or the "Company") announces that on 28 May 2024 the following nil-cost options over ordinary 5p shares in Caledonia were granted to executive directors under the Caledonia Investments 2020 Performance Share Scheme (the "PSS") and in respect of compulsory deferral of bonus under the Caledonia Investments 2020 Deferred Bonus Plan (the "DBP"). The Company's share price used to determine the number of PSS awards and DBP awards was 3410p.

 

Executive Director

No. of shares over which PSS nil-cost options granted

No. of shares over which DBP nil-cost options granted

J M B Cayzer-Colvin

17,617

1,214

M S D Masters

21,620

2,979

R W Memmott

19,223

Nil

Subject to the rules of the PSS, nil-cost options are exercisable between three and ten years after the date of grant. Performance is measured over three years for one-third of the PSS awards which are subject to a post-vesting holding period, on an after-tax basis, of two years. The remaining two-thirds of the awards are subject to performance over five years.

Subject to the rules of the DBP, deferred share awards vest after a three-year retention period.

 

The total number of shares held under option by the above-named executive directors of Caledonia under the Company's performance share schemes following these nil-cost option grants are as follows:

 

Executive Director

Total no. of shares held under option under PSS

Total no. of shares held under option under DBP

J M B Cayzer-Colvin

97,000

10,311

M S D Masters

92,377

11,442

R W Memmott

36,796

Nil

 

Further information required by the Market Abuse Regulation in relation to these transactions is set out in the appendix below.

 

Enquiries:

Richard Webster

Company Secretary

Tel: + 44 20 7802 8080

 

30 May 2024

 

 

APPENDIX

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

James Michael Beale Cayzer-Colvin

2

 

Reason for the notification

 

a)

 

Position/status

 

Executive Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 5p shares

 

 

 

GB0001639920

b)

 

Nature of the transaction

 

 

Grant of nil-cost options over ordinary 5p shares under:

(1) the Caledonia Investments 2020 Performance Share Scheme ("PSS")

 

(2) the Caledonia Investments 2020 Deferred Bonus Plan ("DBP")

 

c)

 

Price(s) and volume(s)

 

 

 

Description

Price(s)

 

Volume(s)

Grant of PSS award

 

£0.00

 

17,617

Grant of DBP award

 

£0.00

1,214

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

18,831

 

Nil

e)

 

Date of the transaction

 

28 May 2024

f)

Place of the transaction

Outside a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Mathew Simon Dexter Masters

2

 

Reason for the notification

 

a)

 

Position/status

 

Director/Chief Executive Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 5p shares

 

 

 

GB0001639920

b)

 

Nature of the transaction

 

 

Grant of nil-cost options over ordinary 5p shares under:

 

(1) the Caledonia Investments 2020 Performance Share Scheme ("PSS")

 

(2) the Caledonia Investments 2020 Deferred Bonus Plan ("DBP")

 

c)

 

Price(s) and volume(s)

 

 

 

 

Description

Price(s)

 

Volume(s)

Grant of PSS award

 

£0.00

 

21,620

Grant of DBP award

 

£0.00

2,979

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

24,599

 

Nil

e)

 

Date of the transaction

 

28 May 2024

f)

Place of the transaction

Outside a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Robert William Memmott

2

 

Reason for the notification

 

a)

 

Position/status

 

Executive Director/Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 5p shares

 

 

 

GB0001639920

b)

 

Nature of the transaction

 

 

Grant of nil-cost options over ordinary 5p shares under the Caledonia Investments 2020 Performance Share Scheme ("PSS")

 

c)

 

Price(s) and volume(s)

 

 

 

 

Description

Price(s)

 

Volume(s)

Grant of PSS award

 

£0.00

 

19,223

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

n/a

 

n/a

e)

 

Date of the transaction

 

28 May 2024

f)

Place of the transaction

Outside a trading venue

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXGDUXUXDGSG
Date   Source Headline
29th Oct 20199:30 amRNSDirector Declaration
7th Oct 201911:33 amRNSNet Asset Value(s)
30th Sep 20193:39 pmRNSHolding(s) in Company
30th Sep 20193:20 pmRNSTransaction in Own Shares
26th Sep 20191:19 pmRNSShare Purchase by Caledonia Employee Share Trust
6th Sep 201912:14 pmRNSNet Asset Value(s)
7th Aug 20199:47 amRNSNet Asset Value(s)
24th Jul 20191:08 pmRNSResult of AGM
10th Jul 20199:00 amRNSAcquisition
4th Jul 20193:29 pmRNSNet Asset Value(s)
1st Jul 20197:00 amRNSBlock listing Interim Review
18th Jun 20198:40 amRNSAnnual Financial Report
10th Jun 20198:09 amRNSDirectorate Change
6th Jun 20191:10 pmRNSNet Asset Value(s)
31st May 20191:52 pmRNSDirector/PDMR Shareholding
29th May 20198:04 amRNSHolding(s) in Company
29th May 20197:00 amRNSFinal Results
7th May 20191:59 pmRNSNet Asset Value(s)
26th Apr 20192:46 pmRNSHolding(s) in Company
5th Apr 201910:55 amRNSNet Asset Value(s)
29th Mar 201912:35 pmRNSLetter to Shareholders - Electronic Communications
29th Mar 201912:15 pmRNSTransaction in Own Shares
6th Mar 20198:23 amRNSNet Asset Value(s)
6th Feb 20193:57 pmRNSNet Asset Value(s)
29th Jan 20199:24 amRNSDirector/PDMR Shareholding
16th Jan 20192:04 pmRNSDirector/PDMR Shareholding
8th Jan 20193:40 pmRNSDirector/PDMR Shareholding
8th Jan 201910:02 amRNSReport for the quarter ended 31 December 2018
8th Jan 201910:00 amRNSNet Asset Value(s)
2nd Jan 20198:31 amRNSBlock listing Interim Review
21st Dec 20189:04 amRNSAcquisition
19th Dec 201810:40 amRNSReclassification of AIC sector
19th Dec 20188:28 amRNSHalf-year Report
6th Dec 20189:47 amRNSNet Asset Value(s)
22nd Nov 20187:00 amRNSHalf-year Report
19th Nov 20182:45 pmRNSDirector Declaration
15th Nov 20187:00 amRNSDirectorate Change
7th Nov 20189:09 amRNSNet Asset Value(s)
23rd Oct 20187:48 amRNSDisposal
15th Oct 20187:00 amRNSAcquisition
4th Oct 20181:57 pmRNSNet Asset Value(s)
6th Sep 20189:41 amRNSNet Asset Value(s)
1st Aug 20181:43 pmRNSPortfolio Update
19th Jul 201812:52 pmRNSResult of AGM
16th Jul 201811:28 amRNSDirectorate Change
13th Jul 20187:49 amRNSAcquisition
6th Jul 201810:34 amRNSReport for the quarter ended 30 June 2018
6th Jul 201810:31 amRNSNet Asset Value(s)
2nd Jul 20188:35 amRNSBlock listing Interim Review
28th Jun 201811:34 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.